Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Stephanos, Hadziyannis"'
Autor:
Margarita Papatheodoridi, Tung‐Hung Su, Emilia Hadziyannis, Chun‐Hsun Liao, Αfroditi Orfanidou, Hung‐Chi Yang, Kalliopi Zachou, Chun‐Jen Liu, Anastasia Kourikou, Nikolaos Gatselis, Spilios Manolakopoulos, George Dalekos, Jia‐Horng Kao, Stephanos Hadziyannis, George V. Papatheodoridis
Publikováno v:
Liver international : official journal of the International Association for the Study of the LiverREFERENCES. 42(3)
Scarce data exist on the effect of nucleos(t)ide analogue (NA) discontinuation on hepatocellular carcinoma (HCC) risk in HBeAg-negative chronic hepatitis B (CHBe-). Therefore, we assessed whether HCC risk is increased in non-cirrhotic CHBe- patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2c6d9403ad8b687e306e04b33ad9a11
https://pubmed.ncbi.nlm.nih.gov/35129291
https://pubmed.ncbi.nlm.nih.gov/35129291
Autor:
Patrick, Marcellin, Ferruccio, Bonino, George K K, Lau, Patrizia, Farci, Cihan, Yurdaydin, Teerha, Piratvisuth, Rui, Jin, Selim, Gurel, Zhi-Meng, Lu, Jian, Wu, Matei, Popescu, Stephanos, Hadziyannis, Q-B, Zhang
Publikováno v:
Gastroenterology. 136(7)
Background & Aims: Patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B treated with peginterferon alfa-2a with or without lamivudine achieve significantly higher 6-month posttreatment rates of response compared with those treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8208abd1bf61d0b3b2b4c8e3ca1b6e43
https://pubmed.ncbi.nlm.nih.gov/19303414
https://pubmed.ncbi.nlm.nih.gov/19303414
Autor:
Chris, Westland, William, Delaney, Huiling, Yang, Shan-Shan, Chen, Patrick, Marcellin, Stephanos, Hadziyannis, Robert, Gish, John, Fry, Carol, Brosgart, Craig, Gibbs, Michael, Miller, Shelly, Xiong
Publikováno v:
Gastroenterology. 125(1)
Hepatitis B virus (HBV) genotype may influence disease progression and antiviral response. We therefore analyzed the frequency and distribution of genotypes in patients from 2 multinational phase III studies of adefovir dipivoxil. Antiviral efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b619c01810e0b8381c06e58ed3c0dab0
https://pubmed.ncbi.nlm.nih.gov/12851876
https://pubmed.ncbi.nlm.nih.gov/12851876
Autor:
Basil Karamanos, Stephanos Hadziyannis
Publikováno v:
Hepatology (Baltimore, Md.). 29(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe883b5135e918296986253af4d14de
https://pubmed.ncbi.nlm.nih.gov/9918906
https://pubmed.ncbi.nlm.nih.gov/9918906
Autor:
George Theodosiadis, Emanuel K. Manesis, Dimitrios Brouzas, Stephanos Hadziyannis, John Kotsiras, Michael Moschos, Constantine Petrou
Publikováno v:
Hepatology (Baltimore, Md.). 27(5)
Following our earlier observation of clinically evident optic tract neuropathy in patients receiving low-dose interferon (IFN) therapy, we prospectively evaluated 53 consecutive patients treated for chronic hepatitis B or C with a median dose of 3 MU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deb34c59d61466f5c494adaf3d310b29
https://pubmed.ncbi.nlm.nih.gov/9581704
https://pubmed.ncbi.nlm.nih.gov/9581704
Autor:
Dimitrios Brouzas, George Theodossiadis, Michael Moschos, Emanouel Manesis, Efthimios Panagakis, Stephanos Hadziyannis
Publikováno v:
Documenta ophthalmologica. Advances in ophthalmology. 94(3)
Patients suffering from chronic viral hepatitis, treated with interferon alpha-2b in a dose of 3 million units trice weekly subcutaneously, were studied. The influence of interferon on the optic nerve was evaluated by measuring the P100 implicit time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24c759b35f2fbf81cdb0cdcdbe099d58
https://pubmed.ncbi.nlm.nih.gov/9682991
https://pubmed.ncbi.nlm.nih.gov/9682991
Autor:
William F. Carman, Winifred Boner, Giovanna Fattovich, Kathryn Colman, Edward S. Dornan, Mark Thursz, Stephanos Hadziyannis
Publikováno v:
The Journal of Infectious Diseases. 177:264-265
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07036af850e2efd25cac6304c6eaf917
https://doi.org/10.1086/517352
https://doi.org/10.1086/517352
Autor:
Christian Bréchot, Franck Jaffredo, David Lagorce, Guido Gerken, Karl Meyer zum Büschenfelde, Anastasia Papakonstontinou, Stephanos Hadziyannis, Raffaela Romeo, Massima Colombo, Joan Rodes, Jordi Bruix, Roger Williams, Nikolai Naoumov
Publikováno v:
European Journal of Gastroenterology & Hepatology. 10:978
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23a613e8f1baa15a0682939c0f349f79
https://doi.org/10.1097/00042737-199811000-00019
https://doi.org/10.1097/00042737-199811000-00019
Autor:
Stephanos Hadziyannis
Publikováno v:
Seminars in Liver Disease; May2006, Vol. 26 Issue 2, p130-141, 12p
Autor:
Rapti I; Irene Rapti, Stephanos Hadziyannis, Liver Unit and its Molecular Biology Laboratory, National and Kapodistrian University of Athens, Evgenidion Hospital of Athens, 15669 Athens, Greece., Hadziyannis S; Irene Rapti, Stephanos Hadziyannis, Liver Unit and its Molecular Biology Laboratory, National and Kapodistrian University of Athens, Evgenidion Hospital of Athens, 15669 Athens, Greece.
Publikováno v:
World journal of hepatology [World J Hepatol] 2015 May 18; Vol. 7 (8), pp. 1064-73.